- Research
- Open access
- Published:
Characteristics of biological parameters and implantable collamer lens (ICL) size selection in moderate, high, and super-high myopia eyes
BMC Ophthalmology volume 25, Article number: 103 (2025)
Abstract
Objective
To analyze the characteristics of anterior segment biometric parameters in moderate, high, and super-high myopia eyes for ICL size selection.
Methods
A total of 246 eyes of 131 patients were included in this prospective observational cohort study. Preoperative axis length (AL), central keratometry (Kc), central corneal thickness (CCT), white-to-white (WTW), internal anterior chamber depth (ACD), trabecular iris angle (TIA), anterior chamber width (ACW), angle-to-angle distance (ATA), crystalline lens rise (CLR), lens thickness (LT), sulcus-to-sulcus (STS), ICL size, and postoperative vault at 1 month were recorded and compared among the different degrees of myopia groups.
Results
The moderate myopia showed smaller ACD and TIA than high and super-high myopia (P < 0.05). A higher proportion of CLR positive (+) was in the moderate myopia group (65%), while the super-high myopia group had a higher proportion of CLR negative (-) (55.3%). (P = 0.047). There were no statistical differences among the myopia groups in WTW, ATA, ACW, STS, LT, and postoperative vault (P>0.05). In different degrees of myopia groups, vertical ATA, ACW and STS were longer than horizontal ATA, ACW and STS (P < 0.001), and horizontal-STS showed a higher correlation with horizontal-ATA (r = 0.655) and horizontal-ACW (r = 0.660) than with WTW (r = 0.591). The 12.1 mm size ICL was slightly selected in moderate myopia (35.8%) more than high myopia (14.6%) and super-high myopia (26.3%) (P = 0.013).
Conclusion
Compared to high and super-high myopia, moderate myopic eyes exhibited smaller ACD, TIA while similar WTW, ATA, ACW and STS, with the lens positioned more anteriorly. It should be concerned to the effect of sagittal axis parameters ACD and CLR on the ICL size in different degrees of myopia.
Introduction
Implantable collamer lens (ICL) implantation is a type of refractive correction surgery that involves implanting an artificial lens, specifically a posterior chamber phakic intraocular lens (pIOL). More than 2 million ICLs have been implanted worldwide [1]. EVO ICL (ICL-V4c, STAAR Surgical Co., Nidau, Switzerland) was first introduced in 2011. Compared to the previous version of Visian ICL (V4), the EVO ICL has a central hole (approximately 360 μm in diameter) in the center of the optic. This hole ensures aqueous humor flow, eliminating the need for laser peripheral iridotomy, thus reducing postoperative complications like elevated intraocular pressure and enhancing surgical safety. Studies have confirmed that implantation of the EVO ICLs is safe, effective, and provides stable refractive outcomes with low rate of adverse events [2,3,4]. It has been reported EVO ICLs could offer better visual quality compared to LASIK, PRK, and SMILE [5]. Unlike laser refractive surgeries that alter the cornea, ICL implantation preserves corneal morphology and biomechanics, providing a larger effective optical zone on the cornea and inducing fewer higher-order aberrations, resulting in superior postoperative visual quality [6–7]. Consequently, ICL implantation has become a popular method for myopia correction.
ICL implantation covers a broad range of refractive errors (-0.5 to -18.0D), catering to patients with low to extremely high myopia. Research has shown that implantation of EVO ICL is safe, effective, and predictable in correcting high and super-high myopia [8]. The overall postoperative corrected distance visual acuity improvement gap in super-high myopic patients was larger than in high myopic patients [9]. An increasing number of patients with low to moderate myopia are concerned about ICL implantation [10]. Several short-term studies have reported the predictability and visual outcomes of ICL implantation for low to moderate myopia (below − 6.00D) are comparable to high myopic patient outcomes [11, 12]. EVO ICL implantation can be considered a viable surgical option for correcting low and moderate myopia, especially in cases where corneal refractive surgery is not recommended [13, 14]. However, the earlier reports primarily focused on ICL predicting vault, safety, and visual quality [15,16,17], few studies conducted on the specificities and differences in anterior segment biometric parameters and their implications for ICL size in different degrees of myopia. It is still uncertain whether the lower the refractive error, the smaller the anterior segment space. Therefore, this paper aims to compare and analyze the anterior segment biometric data of individuals with different levels of myopia, hoping to improve the selection of the suitable ICL size, optimize its positioning, and obtain the optimal vault.
Materials and methods
Study design
This prospective observational cohort study adhered to the principles of the Helsinki Declaration and received ethical approval from the Ethics Committee of Tianjin Medical University Eye Hospital (No.2021KY(L)-18). The study included 131 patients (246 eyes) who underwent ICL implantation at Tianjin Medical University Eye Hospital between September 2021 and December 2022. All patients received routine examinations and met the criteria for ICL implantation. Inclusion criteria were as follows: age 18–50 years, stable refraction, spherical refractive error between − 3.00D and − 20.00D, astigmatism less than − 5.00D, anterior chamber depth (ACD: distance from corneal endothelium to anterior surface of the lens) > 2.8 mm, and endothelial cell count > 2000 cells/mm². Exclusion criteria included corneal scars, corneal ectasia, corneal dystrophy, high intraocular pressure, glaucoma, iris cysts, lens opacity, and previous ocular surgeries.
Preoperative assessment and grouping
Before surgery, all patients underwent ophthalmic examinations, including visual acuity, objective refraction, objective refraction after cycloplegia, and corrected visual acuity. IOP was assessed using a non-contact tonometer (NCT, TX-20 Full Auto Tonometers, Canon, Japan), and anterior segment structures were evaluated with a slit-lamp, followed by a dilated fundus examination. The Pentacam (Pentacam HR, OCULUS Optikgeräte GmbH, Wetzlar, Germany) was used to measure WTW, CCT, Kc. Anterior segment optical coherence tomography (AS-OCT, CASIA-2, TOMEY, Japan) was used to measure anterior chamber depth (ACD), angle-to-angle distance (ATA), anterior chamber width (ACW), crystalline lens rise (CLR), trabecular iris angle (TIA-500). ACD, TIA, and CLR were recorded at the horizontal meridian, while ATA and ACW were recorded at both horizontal and vertical meridians. ATA is the distance between anterior chamber angles along the horizontal (or vertical) meridian, and ACW is the distance between scleral spurs along the horizontal (or vertical) meridian. (Fig. 1) CLR is the distance between the anterior apex of the lens and the ATA line, with positive values (+) for the lens apex anterior to the ATA line and negative values (-) for the posterior. TIA-500 was defined as the trabecular iris angle at 500 μm from the scleral spur, and average values at the nasal and temporal angles were used for statistical analysis. Axis length (AL) was measured using the Lenstar-900 (LS-900, Haag Streit AG, Switzerland), and UBM (MEDA-300 L, China) was utilized to measure sulcus-to-sulcus (STS) and assess ciliary body morphology and cysts. STS refers to the distance between the ciliary sulci in the same meridian direction, measured and recorded for both horizontal and vertical meridians. During measurement, the ciliary sulci must be fully exposed, and measurements should be taken at the attachment point of the root on the iris posterior surface when the ciliary sulcus morphology is normal; if the ciliary sulcus morphology is broad, measure the distance between both sides of bottom ends of the ciliary sulcus.
A single operator performed and reviewed all measurements to ensure consistency, with re-measurement and calibration for significant deviations. ICL size and diopters were determined using the manufacturer’s Online Calculation and Ordering System (OCOS, http://www.ocos.staar.com/). Patients were grouped based on preoperative spherical equivalent (SE) into moderate myopia (-3.25 to -6.00 D), high myopia (-6.25 to -10.00 D), and super-high myopia (> -10.00 D).
Measurement parameters with optical coherence tomography (OCT). The distance between anterior chamber angles (AR-AR) is angle-to-angle (ATA) diameter. The distance from the anterior surface of the crystalline lens to the ATA line (the white line) is the crystalline lens rise (CLR). The anterior chamber width (ACW) from the scleral spur to the scleral spur (SS-SS) is also marked
ICLs surgery
An experienced surgeon (RBY) performed all surgeries. An EVO ICL (ICL-V4c, STAAR Surgical Co., Nidau, Switzerland) was inserted into the anterior chamber through a 3.0 mm corneal incision using an injector cartridge with 2% methylcellulose as a viscoelastic agent. The ICL haptics were positioned into the ciliary sulcus using a lens hook. After pressing the posterior edge of the corneal incision to expel the viscoelastic agent, residual viscoelastic was aspirated, and the corneal incision was sealed with a balanced salt solution. Gatifloxacin, bromfenac sodium and loteprednol were administered postoperatively to control inflammation and prevent infection.
Postoperative vault and ICL size evaluation
Postoperative vault evaluation was conducted one month after surgery. The central vault (distance between the posterior surface of the ICL and the anterior surface of the crystalline lens) was measured using AS-OCT. Eyes with vault within the ideal range (200–800 μm) were assessed to determine the proportion of ideal ICL size selection in each group (Fig. 2).
Statistical methods
The Kolmogorov–Smirnov test was used to determine the normality of the data distribution. Intergroup comparisons were made using one-way ANOVA for normally distributed data and non-parametric tests for non-normally distributed data. Pairwise comparisons were conducted using the Bonferroni correction. Chi-square tests were employed to study differences in composition ratios between groups, with α segmentation for pairwise comparisons. The ideal vault range was defined as 200–800 μm. A P-value < 0.05 was considered statistically significant. Statistical analysis was performed using SPSS (IBM®, SPSS® Statistics, v.26). A minimum sample size of 49 eyes for each group was needed to have a confidence level of 95% that the real value is within ± 5% of the measured value (PASS program 2021, v21.3.0).
Results
Basic characteristics
We ultimately analyzed 131 patients, totaling 246 eyes. The age range of the patients was 18 to 42 years, with 50 males and 81 females. The moderate myopia group (SE: -3.25 to -6.00D) included 60 eyes, the high myopia group (SE: -6.125 to -10.00D) included 101 eyes, and the super-high myopia group (SE: -10.125 to -19.00D) included 85 eyes. The mean SE for each group was − 4.94 ± 0.78D for moderate myopia, -8.01 ± 0.97D for high myopia, and -12.14 ± 3.40D for super-high myopia (Table 1).
Comparison of preoperative parameters
Table 1 shows the statistical differences in certain anterior segment parameters among the three different refractive groups. Significant differences were observed in AL, IOP, CCT, ACD, and TIA among the groups. The AL values for each group were: moderate myopia: 25.49 ± 0.98 mm, high myopia: 26.64 ± 0.99 mm, super-high myopia: 28.38 ± 1.30 mm (P < 0.01), indicating that AL became longer with the increase of myopic diopters. IOP was lowest in the moderate myopia (14.52 ± 2.48 mmHg) and highest in the super-high myopia group (15.65 ± 3.24mmHg), showing a significant difference between the moderate and super-high myopia (P = 0.046). Because of the thin cornea thickness in the moderate myopia group, the IOPs were corrected using Pentacam. The results showed no statistical difference in the three myopia groups (P = 0.590).
For ACD, the moderate myopia (3.17 ± 0.22 mm) had shallower ACD compared to the high myopia (3.26 ± 0.20 mm) and super-high myopia (3.25 ± 0.25 mm) (P = 0.012). No significant difference in ACD was observed between the high and super-high myopia groups (P = 0.998). TIA were smallest in the moderate myopia (48.24 ± 8.62°) and largest in the super-high myopia (54.43 ± 8.36°) (P<0.001). For CCT, There was a significant difference between the three groups (P<0.001). Moderate myopia, high myopia, and super-high myopia were 506 ± 30 μm, 517 ± 28 μm, and 529 ± 36 μm, respectively. This difference might be due to a bias from including patients with thin corneas in the moderate myopia group who were not suitable for corneal refractive surgery.
No significant differences were found in CLR among the different myopia groups. The range of CLR was larger in patients with high myopia (-386 to + 395) and super-high myopia (-450 to + 405) than in patients with moderate myopia (-340 to + 367). The proportion of CLR rise (+) was highest in the moderate myopia (65%) compared to the high myopia (49.5%) and super-high myopia (44.7%). The super-high myopia had the highest proportion of CLR fall (-) at 55.3%, compared to the moderate myopia (35%) and the high myopia (55.3%). The three groups showed significant differences (P = 0.047), with a notable difference between the moderate and super-high myopia (P = 0.016), indicating that the moderate myopia had more forward-placed lenses. In contrast, the super-high myopia had more backward-placed lenses. There were no significant differences between the moderate and high myopia or between the high and super-high myopia (P = 0.056, P = 0.514).
Other parameters, including Kc, WTW, and LT, showed no significant differences among the three groups (P>0.05) (Fig. 3).
Comparison of preoperative parameters in the three myopia groups: axial length (AL) in millimeters; (IOP) in mmHg; central keratometry (Kc) in diopters; central corneal thickness (CCT) in micrometers; white-to-white (WTW) in millimeters; Internal anterior chamber depth (ACD) in millimeters; trabecular iris angle (TIA)in; lens thickness (LT)in millimeters; crystalline lens rise (CLR) in micrometers
There were no significant differences in horizontal ATA (H-ATA), vertical ATA (V-ATA), horizontal ACW (H-ACW), vertical ACW (V-ACW), horizontal STS (H-STS), or vertical STS (V-STS) among the different myopia groups. H-STS was smaller than H-ATA and H-ACW. There were statistical differences in H-STS and H-ATA (P < 0.001), H-STS and H-ACW (P < 0.001). There were no significant differences in V-ATA, V-ACW, and V-STS (Table 2).
The vertical meridian measurements (V-ATA, V-ACW, and V-STS) were larger than the horizontal measurements (H-ATA, H-ACW, and H-STS), indicating vertical elliptical morphology in the anterior and posterior chambers. The difference in ΔSTS (V-STS - H-STS) (0.65 ± 0.38) was greater than the differences in ΔATA (V-ATA - H-ATA) (0.41 ± 0.38) and ΔACW (0.42 ± 0.37) (V-ACW - H-ACW) (P < 0.001), suggesting a more pronounced vertical elliptical shape in the posterior chamber compared to the anterior chamber (Fig. 4). There were no significant differences in ΔATA, ΔACW, or ΔSTS among the different myopia groups (Table 2).
Compared to the correlation in WTW, H-ACW, H-ATA, and H-STS among different myopia groups. The correlation in all refractive myopia was as follows: WTW and H-STS(r = 0.591, P<0.001), H-ACW and H-STS(r = 0.660, P<0.001), H-ATA and H-STS(r = 0.655, P<0.001). The correlation in moderate myopia was as follows: WTW and H-STS(r = 0.745, P<0.001), H-ACW and H-STS(r = 0.770, P<0.001), H-ATA and H-STS(r = 0.770, P<0.001). The correlation in high myopia was as follows: WTW and H-STS(r = 0.432, P<0.001), H-ACW and H-STS(r = 0.563, P<0.001), H-ATA and H-STS(r = 0.565, P<0.001). The correlation in super-high myopia was as follows: WTW and H-STS(r = 0.631, P<0.001), H-ACW and H-STS(r = 0.643, P<0.001), H-ATA and H-STS(r = 0.625, P<0.001) (Fig. 5). The results showed that the correlation in H-ACW and STS, H-ATA and STS were higher than that between WTW and STS, and the same correlation results were observed in moderate myopia and high myopia groups. In the super-high myopia group, the correlation between H-ACW and STS, WTW, and STS was slightly higher than that between ATA and STS.
ICL size selection
The ICL size was determined using the manufacturer’s OCOS calculation formula. The 12.6 mm size had the highest selection proportion in each group: 40.0% in moderate myopia, 63.4% in high myopia, and 44.7% in super-high myopia. The ICL size and proportions in moderate myopia were: 12.1 mm (19 eyes, 31.7%), 12.6 mm (24 eyes, 40.0%), and 13.2 mm (17 eyes, 28.3%). In the high myopia, the ICL size and proportions were: 12.1 mm (14 eyes, 13.9%), 12.6 mm (64 eyes, 63.4%), and 13.2 mm (23 eyes, 22.8%). In the super-high myopia, the ICL size and proportions were: 12.1 mm (20 eyes, 23.5%), 12.6 mm (38 eyes, 44.7%), and 13.2 mm (27 eyes, 31.8%) (Fig. 6).
Comparison of postoperative vault and ICL size in the three myopia groups: A. Comparison of the vault in the three myopia groups; B. Number of eyes and proportion with different ranges of vault (< 200 μm,200–800 μm,800 μm) in the three myopia groups; C. Proportion of ICL size (12.1 mm,12.6 mm,13.2 mm) with actual implantation in each myopia group; D. Proportion of ICL size (12.1 mm,12.6 mm,13.2 mm) with ideal vault in each myopia group
One month postoperatively, vault measurements showed no significant differences among the three groups (P = 0.763). The vaults in the ideal range (200–800 μm) were 88.3%, 87.1%, and 89.4% for moderate, high, and super-high myopia, respectively, with no significant differences (P = 0.891). Only 2 eyes (2%) in the high myopia had a vault < 200 μm. The proportions of vaults > 800 μm were 11.7%, 10.9%, and 10.6% for moderate, high, and super-high myopia, respectively, with no significant differences (P = 0.979).
Excluding data with non-ideal vaults (< 200 μm and > 800 μm), the proportions of suitable ICL size within the ideal vault range (200–800 μm) were re-evaluated. The proportions of ICL size in the moderate myopia group were: 12.1 mm (19 eyes, 35.8%), 12.6 mm (22 eyes, 41.5%), and 13.2 mm (12 eyes, 22.6%). In the high myopia group, the proportions were: 12.1 mm (13 eyes, 14.6%), 12.6 mm (62 eyes, 69.7%), and 13.2 mm (14 eyes, 15.7%). In the super-high myopia group, the proportions were: 12.1 mm (20 eyes, 26.3%), 12.6 mm (35 eyes, 46.1%), and 13.2 mm (21 eyes, 27.6%) (Fig. 6). The 12.6 mm size remained the most commonly selected across all groups. The proportion of 12.1 mm in the moderate myopia group was the highest (P = 0.013), and there was a statistical difference compared with the high myopia group(P = 0.003). The proportion of 12.6 mm was the highest in the high myopia group (P = 0.001), and there were statistical differences between the high myopia group and the moderate myopia group (P = 0.001) and the high myopia group and the super-high myopia group (P = 0.002). The high myopia group had the highest proportion of 13.2 mm, but there was no statistical difference between the three groups (P>0.05).
Discussion
In this study, we primarily evaluated the anterior segment parameters and ICL size selection in patients with varying degrees of myopia. The indication for ICL implantation recommends an ACD > 2.8 mm, as a shallow ACD suggests a small anterior chamber space, which may lead to low vault and increase the risk of lens opacity. Research indicates that vault is related to preoperative ACD [18, 19], and findings suggest that preoperative ACD influences the individual’s range for vault [20]. Therefore, a deeper anterior chamber can accommodate a larger range of vault, while a shallower chamber would have a smaller ideal vault range. Our study found that the ACD in the moderate myopia group was smaller than in the high and super-high myopia groups. Meanwhile, moderate myopia has the smallest TIA. The higher myopic diopters, the larger TIA. Hence, the moderate myopia group has less anterior chamber space than the high and super-high myopia groups, suggesting that the tolerance range for an ideal vault postoperatively in moderate myopia patients is smaller, particularly in those with higher vaults; therefore, vigilance is needed for these patients regarding their vault, anterior chamber angle, and IOP. Besides, ACD measurement error can contribute to inaccuracy of intraocular lens power, which request the more accuracy of preoperative ocular biometry [21, 22]. The use of optical biometers for the best precision of measurement is recommended. AS-OCT is faster and provides more in-depth assessment of the anterior chamber and is repeatable and reproducible [23]. In our research, AS-OCT was used to measure the anterior chamber parameters.
Studies have shown that CLR significantly impacts ACD and postoperative ICL vault [24, 25], with CLR negatively correlated with ACD and vault. Therefore, CLR is considered an essential parameter for predicting vault [16, 26]. This study showed the proportion of CLR + was higher in the moderate myopia group. With the increase of myopic degrees, the proportion of CLR + decreased, and the proportion of CLR- increased. This trend may be related to the negative correlation with ACD, as the moderate myopia group has a smaller ACD, placing the lens in a more anterior position. The study also shows that the range of CLR is greater in the high and super-high myopia groups than in the moderate myopia. Given that LT shows no difference among different myopia groups, we speculate that the greater CLR range in high and super-high myopia patients may be related to zonular function. This suggests that preoperative attention should be given to zonular function in high and super-high myopia patients. Additionally, age could be a factor influencing CLR, with CLR values increasing with age, possibly due to continued lens growth with aging [27].
ATA and ACW represent the horizontal diameters of the anterior chamber. STS is the distance between the ciliary sulci, representing the posterior chamber diameter where the ICL is placed. Our results showed no significant differences in horizontal and vertical ATA, ACW, and STS among different myopia groups, indicating no significant differences in the average anterior and posterior chamber diameters across patients with varying levels of myopia. Thus, combined with the ACD results, we can infer that ACD influences anterior segment space in myopia patients of different degrees. When selecting ICL size, the moderate myopia group with shallower ACD and smaller TIA is more likely to require smaller ICL sizes.
Recently, formulas based on ATA, ACW, and STS parameters for predicting ICL size and vault have been developed [28,29,30]. Our study showed that STS has better correlations with ATA and ACW than WTW. Across different refractive groups, the correlation between ACW and STS was better than between WTW and STS, and ATA correlated with STS better than WTW in the moderate and high myopia groups. Considering the high reproducibility of ATA and ACW parameters provided by anterior segment OCT and minimizing manual measurement errors, ATA and ACW are likely replace WTW for ICL sizing calculations in the future.
Additionally, this study measured the vertical meridian ATA, ACW, and STS using CASIA2. The results were consistent with previous studies [31], confirming that the anterior and posterior chambers are vertically elliptical, with the posterior chamber being more vertically elliptical than the anterior chamber. This provided a theoretical basis for ICL position adjustment (from horizontal to vertical axis) to reduce vertically elliptical the undesirable high vault. Because it did not differ in three myopia groups, non-Toric ICL position adjustment is effective across different refractive groups.
Postoperative vault is influenced by ocular anatomy and ICL size [32, 33]. Su3boptimal ICL size and insufficient vault are the primary reasons for ICL replacement. Thompson et al. reviewed alternative ICL planning and sizing approaches to guide surgeons in implanting ICLs [34]. Our study showed that the proportion of eyes with a postoperative vault in the range of 200–800 μm were 88.3%, 87.1%, and 89.4% in different myopia groups, respectively. Excluding these eyes with non-ideal vaults, the analysis of ICL size distribution within the ideal vault range revealed that the 12.6 mm ICL was the most frequently selected across all groups, especially with 69.7% in the high myopia group. In the moderate myopia group, eyes with a small ACD and a narrow TIA tended to select smaller ICLs (12.1 mm, 35.8%).
In this study, the CCT showed statistical differences among different degrees of myopia, with moderate myopia having thinner CCT compared to high and super-high myopia. The reason is that in the moderate myopia group, most of the patients with thin cornea were unsuitable for corneal refractive surgery, which may have introduced bias.
The limitations of this study include a small sample size, single-center research, and data that may only represent part of the Asian population. Contrary to Hoffer’s protocol, both eyes of 106 patients were included [35]. Future research with larger sample sizes is needed to validate these findings and further explore changes in anterior segment parameters after ICL implantation in different degrees of myopia.
In conclusion, this study confirmed that the anterior segment parameters, ACD and TIA, were smaller in moderate myopia than the high and super-high myopia while similar WTW, ATA, ACW and STS, with the lens position being more anterior. Therefore, for different degrees of myopia, the differences in ICL size were more influenced by sagittal axis parameters. The range of CLR was greater in high and super-high myopia patients, which suggested that we should pay more attention to the zonule function before ICL implantation. The vertical elliptical shape was more evident in the posterior chamber than in the anterior chamber, which confirmed that non-Toric ICL repositioning (from horizontal to vertical axis) was effective across different refractive groups. Furthermore, STS showed a higher correlation with ATA and ACW that are likely replace WTW for ICL sizing calculations in the future.
Data availability
In addition to the data provided in the manuscript, the other datasets used and/or analyzed in the current study are available from the corresponding author upon reasonable request.
References
Wannapanich T, Kasetsuwan N, Reinprayoon U. Intraocular implantable collamer lens with a central hole implantation: safety, efficacy, and patient outcomes. Clin Ophthalmol. 2023;17:969–80. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/OPTH.S3798562.
Papa-Vettorazzi MR, Güell JL, Cruz-Rodriguez JB, Moura-Coelho N, Elies D. Long-term efficacy and safety profiles after posterior chamber Phakic intraocular lens implantation in eyes with more than 10 years of follow-up. J Cataract Refract Surg. 2022;48(7):813–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.jcrs.0000000000000848.
Luo W, Aruma A, Li M, Wang J, Xie J, Xiao X, Shen Y, Niu L, Wang X, Zhou X. Four-year visual outcomes and optical quality of SMILE and implantable collamer lens V4c (EVO-ICL) implantation for high myopia: a retrospective study. BMC Ophthalmol. 2023;23(1):341. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12886-023-03050-9. PMID: 37525155.
Cao K, Zhang J, Wang J, Yusufu M, Jin S, Chen S, Wang N, Jin ZB, Wan XH. Implantable collamer lens versus small incision lenticule extraction for high myopia correction: A systematic review and meta-analysis. BMC Ophthalmol. 2021;21(1):450. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12886-021-02206-9.
Du H, Zhang B, Wang Z, Xiong L. Quality of vision after myopic refractive surgeries: SMILE, FS-LASIK, and ICL. BMC Ophthalmol. 2023;23(1):291. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12886-023-03045-6.
Goes S, Delbeke H. Posterior chamber toric implantable collamer lenses vs LASIK for myopia and astigmatism: systematic review. J Cataract Refract Surg. 2022;48(10):1204–10. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.jcrs.0000000000001007.
Luo W, Aruma A, Li M, Wang J, Xie J, Xiao X, Shen Y, Niu L, Wang X, Zhou X. Four-year visual outcomes and optical quality of SMILE and implantable collamer lens V4c (EVO-ICL) implantation for high myopia: a retrospective study. BMC Ophthalmol. 2023;23(1):341. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12886-023-03050-9.
Chen X, Wang XQ, Xu YL, Cheng MR, Han T, Niu LL, Wang XY, Zhou XT. Five-year outcomes of EVO implantable collamer lens implantation for the correction of high myopia and super high myopia. Eye Vis (Lond). 2021;8(1):40. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40662-021-00264-0.
Wan Q, Chen L, He P, Wei R, Ma K, Yin H, Tang J, Deng YP. Five years comparation of efficacy and safety after ICL-V4c implantation for high and super high myopia correction. Ann Med. 2025;57(1):2448282. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/07853890.2024.2448282.
Alonso-Juárez E, Velázquez-Villoria D. Low diopter Phakic implantable collamer lens: refractive and visual outcomes in low myopia and myopic astigmatism. Clin Ophthalmol. 2022;16:2969–77.
Kamiya K, Shimizu K, Igarashi A, Kitazawa Y, Kojima T, Nakamura T, Oka Y, Matsumoto R. Posterior chamber Phakic intraocular lens implantation: comparative, multicentre study in 351 eyes with low-to-moderate or high myopia. Br J Ophthalmol. 2018;102(2):177–81.
Pinto C, Monteiro T, Franqueira N, Faria-Correia F, Mendes J, Vaz F. Posterior chamber collamer Phakic intraocular lens implantation: comparison of efficacy and safety for low and moderate-to-high myopia. Eur J Ophthalmol. 2021 Apr;22:11206721211012861.
Kamiya K, Shimizu K, Igarashi A, Kitazawa Y, Kojima T, Nakamura T, Ichikawa K, Fukuoka S, Fujimoto K. Japan ICL study group. A nationwide multicenter study on 1-Year outcomes of posterior chamber Phakic intraocular Lens implantation for low myopia. Front Med (Lausanne). 2022;9:762153.
Packer M. The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial. Clin Ophthalmol. 2022;16:3981–3991. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/OPTH.S393422. eCollection 2022.
Rocamora L, Orlando JI, Lwowski C, Kohnen T, Mertens E, Van Keer K. Postoperative vault prediction for Phakic implantable collamer lens surgery: LASSO formulas. J Cataract Refract Surg. 2023;49(2):126–32. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.jcrs.0000000000001079.
Kamiya K, Ryu IH, Yoo TK, Kim JS, Lee IS, Kim JK, Ando W, Shoji N, Yamauchi T, Tabuchi H. Prediction of Phakic intraocular Lens vault using machine learning of anterior segment optical coherence tomography metrics. Am J Ophthalmol. 2021;226:90–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ajo.2021.02.006.
Martínez-Plaza E, de la López A, López-Miguel A, Holgueras A, Maldonado MJ. EVO/EVO + visian implantable collamer lenses for the correction of myopia and myopia with astigmatism. Expert Rev Med Devices. 2023;20(2):75–83. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/17434440.2023.21744293.
Choi KH, Chung SE, Chung TY, Chung ES. Ultrasound biomicroscopy for determining Visian implantable contact lens length in Phakic IOL implantation. J Refract Surg. 2007;23:362–7. https://doiorg.publicaciones.saludcastillayleon.es/10.3928/1081-597X-20070401-08.
Cui W, Wu X, Ren Q, Liu K, Kong F, Wu J. A new formula based on new parameters for predicting postoperative vault after posterior chamber intraocular lens implantation: a retrospective study. Quant Imaging Med Surg. 2023;13(9):5502–10. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/qims-22-1425.
Wu H, Zhong D-J, Luo D-Q, Zhang L-Y, Liu J, Wang H. Improvement in the ideal range of vault after implantable collamer lens implantation: a new vault prediction formula. Front Med Lausanne. 2023;10:1132102. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fmed.2023.1132102.
Stopyra W. The exactness of intraocular lens power calculation formulas for short eyes and correlation between method accuracy and eyeball axial length. Cesk Slov Oftalmol. 2022 Summer;78(5):236–40. https://doiorg.publicaciones.saludcastillayleon.es/10.31348/2022/24. English.
Stopyra W. Analysis of accuracy of twelve intraocular lens power calculation formulas for eyes with axial hyperopia. Saudi J Ophthalmol. 2023;37(2):125–30. https://doiorg.publicaciones.saludcastillayleon.es/10.4103/sjopt.sjopt_64_22.
Gupta N, Varshney A, Ramappa M, Basu S, Romano V, Acharya M, Gaur A, Kapur N, Singh A, Shah G, Chaudhary I, Patel N, Tiwari A, Kate A, Sangwan V, Mathur U. Role of AS-OCT in managing corneal disorders. Diagnostics (Basel). 2022;12(4):918. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/diagnostics12040918.
Gonzalez-Lopez F, Bilbao-Calabuig R, Mompean B, Luezas J, Ortega-Usobiaga J, Druchkiv V. Determining the potential role of crystalline Lens rise in vaulting in posterior chamber Phakic collamer Lens surgery for correction of myopia. J Refract Surg. 2019;35(3):177–83. https://doiorg.publicaciones.saludcastillayleon.es/10.3928/1081597X-20190204-01.
Manito SC, Trancón AS, Sierra OT, Baptista AM, Serra PM. Biometric and ICL-related risk factors associated to sub-optimal vaults in eyes implanted with implantable collamer lenses. Eye Vis (Lond). 2021;8(1):26. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40662-021-00250-6.
Russo A, Filini O, Savini G, Festa G, Morescalchi F, Boldini A, Semeraro F. Predictability of the vault after implantable collamer lens implantation using OCT and artificial intelligence in white patient eyes. J Cataract Refract Surg. 2023;49(7):724–31. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.jcrs.0000000000001182.
Moshirfar M, Han KD, Jaafar MA, et al. Comparative evaluation of multiple nomograms for predicting postoperative vault after implantable collamer lens surgery. J Cataract Refract Surg. 2024;50(1):64–71. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.jcrs.0000000000001304.
Nakamura T, Isogai N, Kojima T, Yoshida Y, Sugiyama Y. Implantable collamer lens sizing method based on swept-source anterior segment optical coherence tomography. Am J Ophthalmol. 2018;187:99–107. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ajo.2017.12.015.
Igarashi A, Shimizu K, Kato S, Kamiya K. Predictability of the vault after posterior chamber Phakic intraocular lens implantation using anterior segment optical coherence tomography. J Cataract Refract Surg. 2019;45(8):1099–104. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jcrs.2019.02.020.
Reinstein DZ, Lovisolo CF, Archer TJ, Gobbe M. Comparison of postoperative vault height predictability using white-to-white or sulcus diameter-based sizing for the Visian implantable collamer lens. J Refract Surg. 2013;29(1):30–5. https://doiorg.publicaciones.saludcastillayleon.es/10.3928/1081597X-20121210-02.
Dong J, Yao J, Chang S, Kanclerz P, Khoramnia R, Wang X. Evaluation of ocular diameter parameters using Swept-Source optical coherence tomography. Med (Kaunas). 2023;59(5):899. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/medicina59050899.
Trancón AS, Manito SC, Sierra OT, Baptista AM, Serra PM. Determining vault size in implantable collamer lenses: preoperative anatomy and lens parameters. J Cataract Refract Surg. 2020;46(5):728–36. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/j.jcrs.0000000000000146.
Zou Q, Zhao S, Cheng L, Song C, Yuan P, Zhu R. Effects of crystalline lens rise and anterior chamber parameters on vault after implantable collamer lens placement. PLoS ONE. 2024;19(3):e0296811. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0296811.
Thompson V, Cummings AB, Wang X. Implantable Collamer Lens Procedure Planning: A Review of Global Approaches. Clin Ophthalmol. 2024;18:1033–1043. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/OPTH.S456397. eCollection 2024.
Hoffer KJ, Aramberri J, Haigis W, Olsen T, Savini G, Shammas HJ, Bentow S. Protocols for studies of intraocular lens formula accuracy. Am J Ophthalmol. 2015;160(3):403–e4051. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ajo.2015.05.029.
Acknowledgements
None.
Funding
Funded by Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-037 A) and National Natural Science Foundation of China (No. 82471049).
Ethics declarations
Ethics approval and consent to participate
The study protocol was approved and the requirement to obtain informed written consent was waived by the Ethics Committee of Tianjin Medical University Eye Hospital (No.2021KY(L)-18). This study was performed in accordance with the tenets of the Declaration of Helsinki.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Li, F., Ma, Y., Qi, W. et al. Characteristics of biological parameters and implantable collamer lens (ICL) size selection in moderate, high, and super-high myopia eyes. BMC Ophthalmol 25, 103 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12886-025-03934-y
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12886-025-03934-y